Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

FSD Pharma Inc. HUGE NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
44/100
1/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

FSD Pharma Inc. (HUGE) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.09. It has a SharesGrow Score of 40/100, indicating a mixed investment profile with 1 out of 7 criteria passed.

Net income is $19M (loss), growing at +15.4%/yr. Net profit margin is 0% (thin). Gross margin is 0% (+0 pp trend).

Balance sheet: total debt is $339,199 against $13M equity (Debt-to-Equity (D/E) ratio 0.03, conservative). Current ratio is 2.44 (strong liquidity). Debt-to-assets is 1.9%. Total assets: $17M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 80/100 (Pass), Past 0/100 (Fail), Health 67/100 (Partial), Moat 28/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

HUGE SharesGrow Score Overview

58/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 80/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 28/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — HUGE

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✓
GROWTH Pass
80/100
HUGE: +0%/yr revenue is, +15.4%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
~
HEALTH Partial
67/100
Balance sheet HUGE: Debt-to-Equity (D/E) ratio 0.03 (conservative), Current ratio is 2.44 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
28/100
HUGE: Gross margin is 0% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 28/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.087-109.1935
Volume22.02M
Avg Volume (30D)196.16K
Market Cap$66.67K
Beta (1Y)0.85
Share Statistics
EPS (TTM)-0.47
Shares Outstanding$39.59M
IPO Date2018-06-08
Employees17
CEOZeeshan Saeed
Financial Highlights & Ratios
Gross Profit$-2.55M
EBITDA$-17.38M
Net Income$-18.56M
Operating Income$-19.93M
Total Cash$3.5M
Total Debt$339.2K
Net Debt$-2.41M
Total Assets$17.47M
Price / Earnings (P/E)-0.2
Analyst Forecast
Company Info
CountryCA
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINCA35954B4047

Price Chart

Track all markets on TradingView
HUGE
FSD Pharma Inc. ↗  ·  NASDAQ Capital Marke
Healthcare • Drug Manufacturers - Specialty & Generic
0.09 52WK RANGE 109.19

People Also View

MKGAF
MKGAF
MERCK Kommanditgesellschaft auf Aktien
$139.41
+4.21%
 LOVFF
LOVFF
Cannara Biotech Inc.
$1.36
-2.58%
 RAMMF
RAMMF
RAMM Pharma Corp.
$0.06
+0.00%
 BFRI
BFRI
Biofrontera Inc.
$1.06
-2.75%
 SHMN
SHMN
SOHM, Inc.
$0.00
+0.00%
 SXTC
SXTC
China SXT Pharmaceuticals, Inc.
$1.86
-10.58%
 CVGRF
CVGRF
City View Green Holdings Inc.
$0.03
-4.57%
 INQD
INQD
Indoor Harvest Corp
$0.00
+100.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message